Soo Jin Na1, Chi Ryang Chung1, Yang Hyun Cho2, Kyeongman Jeon3, Gee Young Suh3, Joong Hyun Ahn4, Keumhee C Carriere5, Taek Kyu Park6, Ga Yeon Lee6, Joo Myung Lee6, Young Bin Song6, Joo-Yong Hahn6, Jin-Ho Choi6, Seung-Hyuk Choi6, Hyeon-Cheol Gwon6, Jeong Hoon Yang7. 1. Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 2. Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 3. Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 4. Biostatistics and Clinical Epidemiology Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 5. Biostatistics and Clinical Epidemiology Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, Alberta, Canada. 6. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 7. Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: jhysmc@gmail.com.
Abstract
INTRODUCTION AND OBJECTIVES: This study investigated whether the vasoactive inotropic score (VIS) is independently predictive of mortality in cardiogenic shock (CS). METHODS: This study was retrospective, observational study. Patients who were admitted to the cardiac intensive care unit from January 2012 to December 2015 were screened, and 493 CS patients were finally enrolled. To quantify pharmacologic support, the patients were divided into 5 groups based on a quintile of VIS: 1 to 10, 11 to 20, 21 to 38, 39 to 85, and > 85. The primary outcome was in-hospital mortality. RESULTS: In-hospital mortalities in the 5 VIS groups in increasing order were 8.2%, 14.1%, 21.1%, 32.0%, and 65.7%, respectively (P < .001). Multivariable analysis indicated that VIS ranges of 39 to 85 (aOR, 3.85; 95%CI, 1.60-9.22; P = .003) and over 85 (aOR, 10.83; 95%CI, 4.43-26.43; P < .001) remained significant prognostic predictors for in-hospital mortality. With multiple logistic regression to remove any confounding effects, we found that the localized regression lines regarding the odds of death intersected each other's (medical therapy alone and combined extracorporeal membrane oxygenation group) path at VIS = 130. In contrast to linear correlation between VIS and mortality for patients treated with medical therapy alone, there was little association between a VIS of 130 or more and the probability of in-hospital mortality for patients who were treated with extracorporeal membrane oxygenation. CONCLUSIONS: A high level of vasoactive inotropic support during the first 48hours was significantly associated with increased in-hospital mortality in adult CS patients.
INTRODUCTION AND OBJECTIVES: This study investigated whether the vasoactive inotropic score (VIS) is independently predictive of mortality in cardiogenic shock (CS). METHODS: This study was retrospective, observational study. Patients who were admitted to the cardiac intensive care unit from January 2012 to December 2015 were screened, and 493 CS patients were finally enrolled. To quantify pharmacologic support, the patients were divided into 5 groups based on a quintile of VIS: 1 to 10, 11 to 20, 21 to 38, 39 to 85, and > 85. The primary outcome was in-hospital mortality. RESULTS: In-hospital mortalities in the 5 VIS groups in increasing order were 8.2%, 14.1%, 21.1%, 32.0%, and 65.7%, respectively (P < .001). Multivariable analysis indicated that VIS ranges of 39 to 85 (aOR, 3.85; 95%CI, 1.60-9.22; P = .003) and over 85 (aOR, 10.83; 95%CI, 4.43-26.43; P < .001) remained significant prognostic predictors for in-hospital mortality. With multiple logistic regression to remove any confounding effects, we found that the localized regression lines regarding the odds of death intersected each other's (medical therapy alone and combined extracorporeal membrane oxygenation group) path at VIS = 130. In contrast to linear correlation between VIS and mortality for patients treated with medical therapy alone, there was little association between a VIS of 130 or more and the probability of in-hospital mortality for patients who were treated with extracorporeal membrane oxygenation. CONCLUSIONS: A high level of vasoactive inotropic support during the first 48hours was significantly associated with increased in-hospital mortality in adult CS patients.
Authors: Cvetan Trpkov; Jordan D Gibson; Robert J H Miller; Andrew D M Grant; Gregory Schnell; Bryan J Har; Brian Clarke Journal: CJC Open Date: 2020-05-18
Authors: Richard G Jung; Pietro Di Santo; Rebecca Mathew; Omar Abdel-Razek; Simon Parlow; Trevor Simard; Jeffrey A Marbach; Taylor Gillmore; Brennan Mao; Jordan Bernick; Pascal Theriault-Lauzier; Angel Fu; Lawrence Lau; Pouya Motazedian; Juan J Russo; Marino Labinaz; Benjamin Hibbert Journal: J Am Heart Assoc Date: 2021-10-29 Impact factor: 5.501
Authors: Bui Hai Hoang; Phuc Giang Do; Lac Duy Le; Thao Thi Huong Bui; Thinh Nghia Bui; Quan Minh Nguyen; Duong Hoang To; Anh Dat Nguyen; Michael M Dinh; Samuel Z Goldhaber; Richard Day; Hieu Lan Nguyen Journal: Clin Appl Thromb Hemost Date: 2021 Jan-Dec Impact factor: 2.389
Authors: Muharrem Akin; Vera Garcheva; Jan-Thorben Sieweke; Ulrike Flierl; Hannah C Daum; Johann Bauersachs; Andreas Schäfer Journal: PLoS One Date: 2020-11-03 Impact factor: 3.240